Live feed
Filing
SC 13D/A
SC 13D/A0001072613-21-000667·Growth Equity Opportunities V, LLC
Schedule 13D ownership disclosure
Regulus Therapeutics Inc.
Security class unavailable · CUSIP: 75915K101
Event date: 2021-11-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-21-000667
- Form type
- SC 13D/A
- Filer
- Growth Equity Opportunities V, LLC
- CIK
- CIK 1706444
- Filed
- Dec 09, 2021
- Reporting period
- Nov 30, 2021
- Description
- Schedule 13D beneficial ownership